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Abstract Cryopreserved pulmonary homograft
(CPH) implantation remains the gold standard for
reconstruction of the right ventricular outflow tract
(RVOT). Harvesting homografts\ 24-h post mortem
is the international norm, thereby largely excluding
cadaveric donors. This study examines the structural
integrity and stability of ovine pulmonary homografts
harvested after a 48-h post mortem period, cryopre-
served and then implanted for up to 180 days. Fifteen
ovine pulmonary homografts were harvested 48-h post
mortem and cryopreserved. Five CPH served as a
control group (group 1; n = 5). CPHwere implanted in
the RVOT of juvenile sheep and explanted after
14 days (group 2; n = 5) and 180 days (group 3;
n = 5). Leaflet integrity was evaluated by strength
analysis, using tensile strength (TS), Young’s modulus
(YM) and thermal denaturation temperature (Td), and
morphology, including haematoxylin and eosin
(H&E), Picrosirius red staining, scanning electron
microscopy (SEM), transmission electron microscopy
(TEM) and von Kossa stains. Echocardiography
confirmed normal function in all implants. In explants,
no reduction in TS, YM or Td could be demonstrated
and H&E showed mostly acellular leaflet tissue with
no difference on Picrosirius red. TEM demonstrated
consistent collagen disruption after cryopreservation
in all three groups, with no morphological deteriora-
tion during the study period. von Kossa stains showed
mild calcification in group 3. No deterioration of
structural integrity could be demonstrated using
strength or morphological evaluations between the
controls and implant groups over the study period.
Extending the post mortem harvesting time of homo-
grafts beyond 24 h did not appear to negatively affect
the long-term performance of such transplanted valves
in this study.
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Introduction
Cryopreserved pulmonary homografts remain the gold
standard for reconstruction of the RVOT (Hechadi
et al. 2013). However, availability has been the
Achilles heel of homograft-based surgery, because
of donor shortages (Yoshikawa et al. 2000). In 1987,
O’Brien et al. (1987a) described the use of viable
cryopreserved homografts, which introduced the era
of homograft banking. The possibility of delaying
homograft degeneration by using viable cryopreserved
homografts or homovital homografts (Yacoub et al.
1995) became a well-established concept and homo-
graft banks across the world started using cryopre-
served homografts or homovital homografts. Viable
cryopreserved homografts are harvested from beating
heart donors, and less than 6 h and definitely less than
24 h post mortem in the case of cadaveric donors
(O’Brien et al. 1987a). Homovital homografts are
untreated homografts harvested under sterile condi-
tions, usually from the recipient at the time of the heart
transplantation, and kept in nutrient medium. These
homografts are considered viable if implanted within a
few days (Yacoub et al. 1995). The post mortem
harvesting time of homografts is restricted to a
maximum of 24 h by most tissue banks internationally
(Dawson and Brockbank 1997). Strict adherence to
this criterion reduces the potential homograft pool, as
the so-called donor consent window of opportunity is
restricted, thereby reducing the potential cadaver
donor pool to mainly in-hospital deaths. Potential
cadaveric donors who never reach the hospital, for
example suicide or traffic deaths, are not recruited
either, due to the absence of specific cadaver donor
programmes. In South Africa, nearly 70,000 medico-
legal autopsies are performed annually. Reactivating
cadaver donor programmes has the potential to
address general shortages; however, this might require
extending the post mortem harvesting time to beyond
24 h. At the Bloemfontein homograft bank, which is
largely dependent on cadaver donors, the mean post
mortem ischaemic time is 33 h, and it has extended its
harvesting times to 48 h with sound results (Botes et al.
2012). Despite detailed studies of homograft viability,
endothelial changes (Angell et al. 1989; O’Brien et al.
1995; Yankah and Hetzer 1987) and post mortem
cellular changes, the importance of preserved structure
and function is still uncertain.
Historically, homografts were harvested from
cadavers, and harvesting times varied widely (Botes
et al. 2012; O’Brien et al. 1987a). Homografts were
stored at 4 C in an antibiotic solution for up to 90
days (Yacoub and Kittle 1970). Despite O’Brien’s
claims to the contrary in a medium-term follow-up
series (O’Brien et al. 1995, 2001), no difference could
be demonstrated between fresh antibiotic homografts,
group 1, and viable cryopreserved homografts, groups
2 and 3, in a long-term follow-up series (O’Brien et al.
1987b, 2001). Several other centres have also reported
good medium-term results with fresh antibiotic-pre-
served homografts (Yacoub et al. 1995; Langley et al.
1996).
It is known that humoral and cellular immunolog-
ical responses to viable endothelium are pronounced
(Methe et al. 2007) and that homovital homografts
might be rejected (Green et al. 1998). Mitchell et al.
(1998) believe that most, if not all, homografts, are
eventually essentially dead and acellular and only
survive as a scaffold.
The period between harvesting and cryopreserva-
tion comprises a culture and a sterilisation phase,
which range in length between different tissue banks
(between 24 and 75 h) (Langley et al. 1996; Barrett-
Boyes 1987). Cryopreservation within 3–4 days is
accepted for viable cryopreserved homografts
(O’Brien et al. 1987a, b). This means that the actual
accepted post mortem ischaemic time before cryop-
reservation is routinely somewhere between 48 and 96
h. Insisting on a post mortem harvesting time of less
than 24 h is therefore questionable from a structural
point of view. However, extending homograft har-
vesting times can increase bacterial exposure, esca-
lating the bio-burden and therefore contributing to
graft failure and calcification (Brubaker et al. 2016;
Mroz et al. 2008). However, microbiological exami-
nations yielded similar results in the 24 and 48-h post
mortem groups harvested from intact sheep carcasses
as described by Smit et al. (2015). Furthermore, no
fungi were cultured and all samples were free of
organisms after 24 h incubation in an antibiotic
solution. The Bloemfontein homograft bank has
previously indicated that extending the post mortem
harvesting time up to 72 h had no deleterious effect on
homograft structure and functioning in the juvenile
ovine model (Smit et al. 2015).
In this study, cryopreserved homografts that had
been harvested 48 h post mortem were implanted in
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juvenile ovine models for either 14 or 180 days and,
after explantation, compared to non-implanted cryop-
reserved homografts. The aim of this experimental
study was to evaluate the structural stability and
integrity of the homografts and to assess modes of
failure, if applicable.
Materials and methods
All experiments were performed in accordance with
the Principles of Laboratory Animal Care prepared by
the National Society of Medical Research, and the
Guide for the Care and Use of Laboratory Animals
prepared by the Institute of Laboratory Animal
Resources and published by the US National Institute
of Health 1996 (http://www.nap.edu/catalog/5140.
html). Approval of the study protocol was obtained
from the Animal Ethics Committee of the University
of the Free State (ETOVS Number: UFS–AED2016/
0101).
Pulmonary homograft harvesting and preparation
A block removal of all intrathoracic organs as well as
the attached liver was performed immediately after
slaughtering from fifteen female juvenile Merino
sheep [mean age 4.5 months, mean body weight
27.4 ± 1.14 kilograms (kg)]. Each tissue block with
remaining blood was lifted from the carcass and sealed
in a sterile container without any additives. The tissue
blocks were left for 6–8 h at room temperature
representing ‘‘warm ischaemic time’’, and then stored
at 4 C for an additional 40 h, representing ‘‘cold
ischaemic time’’. At 48 h post mortem the containers
were opened and the pulmonary homografts (PH) were
dissected from the tissue blocks while being washed in
copious amounts of Ringers lactate. The PHs were
incubated overnight (mean 20 h) at 4 C in an
antibiotic solution containing 100 ml of Medium199
with Earle’s Base (Whitehead Scientific (Pty) Ltd.,
Brackenfell, South Africa), 2.5 mg Fungizone (Bris-
tol-Meyers Squibb, Johannesburg, South Africa),
25 mg Amikacin (Fresenius, Bodene (Pty) Limited
trading as Intramed, Johannesburg, South Africa),
100 mg Vancomycin (Gulf Drug Company (Pty) Ltd,
Mount Edgecombe, South Africa) and 50 mg Piper-
acillin (Sabax, Johannesburg, South Africa) for ster-
ilization. The homografts were then cryopreserved as
previously described (Smit et al. 2015) after tissue
samples had been obtained for microscopy, microbi-
ological cultures and sensitivity (MC&S).
Five of these homografts served as controls (n = 5)
and were not implanted into recipient sheep. The ten
remaining pulmonary homografts were implanted into
recipient sheep and explanted after 14 days (n = 5)
and 180 days (n = 5) respectively in order to evaluate
their structural integrity and stability (Fig. 1). Leaflet
integrity was evaluated by morphology and strength
analysis. Strength analyses included TS, YM and Td,
while morphology included H&E, Picrosirius red
staining, SEM, TEM and von Kossa stains. Wethers
of the Dorper strain were used as recipient animals,
and each recipient received an ear tag with a unique
identification number.
Cryopreservation and thawing
Cryopreservation was performed using an automated
programmable freezer (Cryoson BV-9 Biological
Freezer, Consarctic, Scho¨llkrippen, Germany). Before
cryopreservation 11 ml of dimethyl sulphoxide
(DMSO) (Sigma-Aldrich, Midrand, South Africa)
was added to 100 ml of M199. Homografts were
stored in a double package sachet in a storage vessel in
the vapor phase of liquid nitrogen (LN2) between
- 120 and- 160 C until they were implanted. It was
confirmed that all HPs cryopreserved were culture
negative on pre-cryopreservation MC&S. Five of
these pulmonary homografts were used as controls
and the remaining ten homografts were implanted into
male juvenile sheep.
Before implantation, homografts were thawed in a
water bath at 35–40 C for 5–7 min until they were
about 80% thawed. Both packages were opened
aseptically and the homograft was transferred into a
bowl with 500 ml cold (4 C) M199, allowing a
10-min rinse period with gentle shaking to extract
most of the DMSO from the homograft tissue. This
procedure was repeated in a second bowl of cold
M199, and thereafter the homograft was delivered to
the surgical team for final trimming and implantation.
Another tissue sample was obtained for MC&S at
implantation to confirm sterility.
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Pulmonary homograft implantation
Recipient sheep (mean age 6.8 months; body weight
40.2 ± 6.38 kg) were premedicated with 0.175 mg/
kg Neurotranq (VirbacRSA (Pty) Ltd, Halfway House,
South Africa) and 0.2 mg/kg Atropine (Bayer (Pty)
Ltd, Animal Health Division, Isando, South Africa)
intramuscularly, and anaesthesia was induced intra-
venously with Bomathal (12 mg/kg IV, Merial SA
(Pty) Ltd, Halfway House, Johannesburg, South
Africa). After positioning the sheep in a lateral
decubitus position they were intubated and ventilated.
Cardiopulmonary bypass was obtained by arterial
cannulation via the left carotid artery and venous
cannulation via the right atrium (Dagum et al. 1999).
The stump pressure of the tied-off distal carotid artery
was used as an index of invasive arterial pressure. A
central line was inserted into the left jugular vein and
the surgical procedure was performed on a beating
heart.
A mini-thoracotomy was performed on the left side
of the sheep and the fourth rib was removed. The
pulmonary artery was transected, the native pul-
monary valve leaflets resected and the pulmonary
homograft was implanted as an RVOT conduit with
two continuous 4/0 polypropylene suture
anastomoses.
After implantation, the recipient was weaned off
cardiopulmonary bypass, the mini-thoracotomy
closed in layers and a chest drain was inserted.
Systemic pain medication (2 mg Morphine sulphate,
Bodene (Pty) Ltd, trading as Intramed, Port Elizabeth,
South Africa) was administered intramuscularly twice
a day and 5 mg Depomycin (Intervet SA (Pty) Ltd,
Johannesburg, South Africa) as antibiotic was admin-
istered daily for 5 days post-operatively. Animals were
extubated between 2 and 4 h post-operatively. Chest
drains were removed before the animals were trans-
ferred to an overnight facility with a companion sheep
to alleviate stress on the recipient sheep.
Fig. 1 Study layout
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Biomechanical testing
The biomechanical properties of the control homo-
graft leaflets and the ten explanted valvular leaflets
were examined using a TS testing apparatus (Lloyds
LS100 Plus, IMP, Johannesburg, South Africa).
Briefly, the pulmonary leaflets were fixed into clamps
at both ends and gradually stretched (0.1 mm/s) by
applying tension on both ends (Thubrikar et al. 1983).
TS and YM were calculated from the stress–strain
curves and automatically recorded on the comput-
erised apparatus. The YMwas calculated by taking the
derivative of the stress–strain curve, where the largest
value was chosen before breakage. The TS, measured
in Pa, is calculated as the force divided by the cross-
sectional area of the leaflet.
In Td, the rate of heat flow to the sample is
compared to the rate of heat flow to an inert material,
while the materials are heated or cooled concurrently.
For proteins, the thermally induced process
detectable by Td is the structural malting or unfolding
of the molecule. The transition of protein from a native
to a denatured conformation is accompanied by the
rupture of inter- and intra-molecular bonds, and the
process has to occur in a cooperative manner to be
discerned by Td (Smith and Judge 1991). This was
recorded as Td for each group (Ru¨egg et al. 1975). Td
analysis was performed using a differential scanning
calorimeter (DSC) (Mettler Toledo, Td 822e, Micro-
sep, Johannesburg, South Africa). Small samples of
the pulmonary leaflets (2–5 mg) were placed in the
DSC’s hermetically sealed pans and subjected to
temperature increasing at a rate of 10 C/min from 25
to 95 C. The maximum temperature of protein Td was
electronically recorded for each sample.
Histology
Samples from the middle of each pulmonary homo-
graft leaflet was processed by the Department of
Anatomical Pathology of the National Health Labo-
ratory Services in Bloemfontein using standard oper-
ative procedures. The specimens were embedded in
paraffin wax (Siemens, Johannesburg, South Africa)
and two micrometer thick longitudinal sections were
prepared and routinely processed for H&E, Picrosirius
red and von Kossa staining. The impact of ischaemic
time on the structural integrity of pulmonary valvular
leaflet tissue was evaluated by performing H&E
staining to display cytoplasmic, nuclear, and extracel-
lular matrix features, Picrosirius red staining to study
the collagen networks and von Kossa staining to
observe the degree of leaflet calcification.
Electron microscopy
Scanning electron microscopy
Each pulmonary homograft tissue sample for SEM
was prepared by the Centre for Microscopy at the
University of the Free State. All samples were fixed in
2.5% glutaraldehyde (Merck, Johannesburg, South
Africa). Homograft leaflets were divided into two
specimens of approximately 3 mm 9 6 mm. Tissue
specimens were dried using the critical point method
(Tousimis critical point dryer, Rockville, Maryland,
USA, ethanol dehydration, carbon dioxide drying gas)
and were metallised using gold (BIO-RAD, Micro-
science Division Coating System, London, UK; Au/Ar
sputter coating @ 50–60 nm). Evaluations were
performed with a Shimadzu SSX 550 scanning
electron microscope (Kyoto, Japan, with integral
imaging (SDF, TIF and JPG format). The surface area
of each specimen was examined and photographed in
either four or five different positions, and all images
were then evaluated by three independent assessors
and a score allocated. SEM micrographs were used to
assess endothelial integrity and the effect of cryop-
reservation on endothelium integrity, and to evaluate
the quality of the extracellular basal membrane.
Transmission electron microscopy
Pulmonary leaflet samples were fixed in 3.0% glu-
taraldehyde overnight, post fixated in Palade’s
osmium tetroxide, and dehydrated in a graded acetone
series. Dehydrated samples were impregnated/embed-
ded in an epoxy (Spurr 1969) to facilitate the making
of ultra-thin sections for the TEM evaluation. Ultra-
thin sections were cut from the sample embedded in
the epoxy using an ultra-microtome (Leica Ultracut
UC7, Vienna, Austria). After sectioning, the samples
were stained with uranyl acetate and lead citrate.
Sections of the leaflet samples were evaluated by using
a transmission electron microscope (CM100, FEI,
Netherlands) and photographed using an Olympus
Soft Imaging System Megaview III digital camera
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with Soft Imaging System digital image analysis and
documentation software (Olympus, Tokyo, Japan).
Echocardiography
The ten implanted pulmonary homografts were
explanted after either 14 days (n = 5) or 180 days
(n = 5). Before the animal was sacrificed a transtho-
racic echocardiograph was done using a Philips
Envisor Ultra Sound system (Philips, Johannesburg,
South Africa) with a 3.5 MHz probe to ensure patency
of the implanted homografts. Pulmonary insufficiency
was evaluated semi-quantitatively with pulsed wave,
continuous wave and colour Doppler flow on the
parasternal short-axis view. Each measurement was
repeated six times and mean values were calculated.
The regurgitation jet across the homograft was graded
by identification length and width into the RVOT and
mapped as: none/trivial, mild, moderate or severe,
using standard echocardiography criteria. The mean
flow velocities across the implanted homografts were
obtained by the use of continuous wave Doppler. Each
measurement was repeated six times and the mean
value over the measurements was calculated. Animals
were only identified by their individual ear tag
numbers, allowing blinded evaluation by the
sonographer.
Gross examination
One surgeon and five researchers inspected the
explanted homografts visually in a blinded manner.
The general appearance of the homograft leaflets was
evaluated for fenestrations, retraction, thrombotic
material and atheroma or calcification.
Statistical analysis
The unpaired t test was used to compare the TS, YM
and Td explant results after 14 days and 180 days to
that of the control. The null hypothesis assumes that
the population means of the two independent samples
are equal. The mean difference (positive or negative)
was calculated, as well as a 95% CI for the mean
difference (indicating the limits within which the true
difference is likely to occur).
Results
Microbiology
All homograft tissue samples were culture negative
before cryopreservation as well as before
implantation.
Echocardiography
All the homografts functioned normally and no more
than mild regurgitation was recorded in any of the
homografts. None of the homografts had more than
minimal regurgitation or demonstrated a maximum
instantaneous gradient of more than 20 mmHg. No
leaflet calcification could be demonstrated (Fig. 2).
Gross examination
Blinded visual inspection did not discern differences
in the macroscopic appearance of homografts
explanted after 14 days and 180 days (Fig. 3).
Biomechanical testing
The strength analysis results are summarised in
Table 1. There were no significant differences in TS,
YM and Td between the control and 14-day explanted
leaflets. Although TS of the control and the 180-day
explanted leaflets did not differ significantly, the trend
was towards stronger explanted leaflets, because the
value of the lower limit of the 95%CI was much closer
to zero than the upper limit. YM of the 180-day
explanted leaflets was significantly higher than that of
the control leaflets. Td of control and 180 day explants
did not differ significantly. No deterioration of
strength could be demonstrated over the study period.
Histology
Figure 4 represents the H&E, Picrosirius red and von
Kossa staining of the 48 h control, 14-day and 180-day
explants.
The H&E stains show that endothelium covered the
leaflets in a monolayer in the control, the 14 days and
the 180 days explanted leaflets. Picrosirius red stains
for collagen did not differ between the three groups
and the von Kossa stains showed no calcification of the
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14 days explanted leaflets and only mild calcification
of the 180 days explanted leaflets (Fig. 4).
Electron microscopy
SEM confirmed an endothelial layer that was visible in
the control, the 14-day and the 180-day explants. SEM
Fig. 2 Transvalvular gradient of a 180-day homograft (Smit 2011)
Fig. 3 aMacroscopic appearance of 14-day explanted homograft leaflet. bMacroscopic appearance of 180-day explanted homograft
leaflet
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after cryopreservation and at 14 days shows endothe-
lial cells with prominent nuclei, collapsed extra-
nuclear areas and areas of dehiscence from the basal
membrane. In contrast, the 180-day samples show a
confluent layer of healthy endothelium (Fig. 5). TEM
demonstrates consistent collagen disruption after
cryopreservation in the control group as well as the
14 days and 180-day explants with no morphological
deterioration or changes during the study period
(Fig. 5).
Discussion
In an attempt to broaden the scientific basis for
extending cadaveric homograft harvesting times,
which could attenuate the worldwide shortage of
homografts, this study was conducted in the juvenile
sheep model. The study focuses on the structural
integrity and stability of homografts sterilized and
cryopreserved after 48 h post mortem ischaemic time,
a time specifically chosen to simulate a reasonable
window of opportunity in order to obtain donor
Table 1 TS, YM and Td of 48 h cryopreserved ovine leaflets before implantation (control, n = 5) and explanted leaflets after
14 days (n = 5) and 180 days (n = 5)
Variable Mean
control
Mean 14 day
explant
95% CI control versus 14 day
explant
Mean 180-day
explant
95% CI control versus 180-day
explant
TS 2.461 2.788 - 1.273; 1.927 4.801 - 0.303; 4.983
YM 10.001 11.057 - 7.695; 9.770 25.388 1.819; 28.954*
Td 70 72 - 0.765; 4.265 70 - 3.785; 4.005
Values are given as a mean and the 95% CI of the difference between the control and 14 and 180 days after implantation (*p\ 0.05)
TS Tensile strength, YM Young’s modulus, Td thermal denaturation temperature
Fig. 4 H&E, Picrosirius red and von Kossa staining of 48 h cryopreserved ovine leaflets before implantation (control, n = 5), and
explanted leaflets after 14 days (n = 5) and 180 days (n = 5). h Hours, H&E Haematoxylin and eosin, VK von Kossa
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consent in human cadaveric donor programmes in
South Africa (mean = 33 h). The ovine model is a
widely accepted model for homograft degeneration
studies and is well known for its aggressive calcifica-
tion potential. The ideal is to use primate models for
implantation, but this model is very expensive and
severely regulated. Although the study revealed
excellent results about tissue integrity among the
groups, final conclusions and translation to human
subjects can only be made once a similar study has
been repeated in a primate model.
A limitation of the ovine model is that the
fermenting rumen in the large stomach of sheep
generates heat post mortem in intact carcasses. In a
previous study, the stomach was removed from
carcasses otherwise left intact. In that study cultures
were obtained from homograft tissue harvested up to
72 h post mortem. The homografts were incubated in
Medium199 and antibiotics as described. The homo-
grafts were consistently culture negative before cry-
opreservation and no differences in the outcome at
180 days implantation could be demonstrated between
the groups extending harvesting time up to 72 h (Smit
et al. 2015). While the organ blocks harvested in this
study accurately reflects post mortem ischaemic time
as well as confirmed sterility pre-cryopreservation and
at implantation (as with human homografts), it does
not accurately reflect the effects of temporary bacterial
exposure associated with decomposition in human
cadavers that might occur before organ explantation
and antibiotic incubation.
The 48 h post mortem harvested cryopreserved
pulmonary homografts performed well over the study
period, maintained its tissue integrity and stability and
exhibited no graft failures. This correlates well with
findings by researchers in Sweden that transplanted
valves in the pulmonary position from non-beating
donors with[ 24 h ischaemic time and longer times
from retrieval to cryopreservation had a lower rein-
tervention rate compared to\ 24 h. They concluded
that longer ischaemic times of donor valves might
even be preferable and does not affect the long-term
outcome of transplanted homografts negatively (Ax-
elsson and Malm 2018).
All the homografts functioned well, as assessed by
echocardiography before euthanasia, after a minimum
post-operative follow-up period of 180 days. None of
the homografts showed gradients in excess of
20 mmHg or more than mild pulmonary regurgitation
([ 2/4). No calcification could be demonstrated in the
leaflets in either the 14 day or 180 day groups, and
only mild calcification occurred in the homograft wall,
but only in the 180-day group.
Gross macroscopic inspection after euthanasia
confirmed the absence of homograft degeneration in
both groups. Mild, spotty calcification in the homo-
graft walls occurred in two of the 180-day explant
valves.
Fig. 5 SEM and TEM of 48 h cryopreserved ovine leaflets before implantation (control, n = 5) and explanted leaflets after 14 days
(n = 5) and 180 days (n = 5). SEM Scanning electron microscopy, TEM transmission electron microscopy, h hours
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We speculate that the increase in TS and YM seen
in the 180-day explant group compared to both the
control and the 14-day explant can be related to pannus
or neo–collagen. It is important to note that no
deterioration of strength occurred during the study
period. It was therefore concluded that strength is
maintained in the 48 h post mortem cryopreserved
homografts during the study period. Td values
remained constant between the groups and no deteri-
oration could be demonstrated in the 48 h post mortem
cryopreserved homografts over the 180-day implan-
tation period.
Histology showed progressive loss of cellularity
over the study period, with 180 days explanted
homograft leaflets being essentially acellular, as
previously described by Mitchell et al. (1998). The
14 days explanted homografts showed mononuclear
infiltrates, composed primarily of T-lymphocytes, that
were diffuse but not prominent in most valves and
which were generally comparable with those seen in
the control group. The endothelial cells appeared
focally and variably demonstrable in the control
group, tattered in the 14 days explant group but
‘‘healthy‘‘in the 180 days explants (group 3), because
these cells are probably of recipient origin. The
Picrosirius red staining confirmed the presence of
collagen in all groups and the von Kossa staining
showed mild calcification in the 180-day explant
group.
SEM studies highlighted the abnormal endothelium
after cryopreservation maintained in the 14-day group;
however, a pristine endothelial layer was present in the
180 day explants. TEM clearly demonstrated damage
to the collagen scaffold caused by cryopreservation, as
previously described by Schenke-Layland et al.
(2006). This disruption of the collagen matrix was
sustained throughout the study period and was similar
between all groups.
This study demonstrated severe disruption caused
by cryopreservation and this damage remained con-
stant during the study period. The fact that no
reorganisation of the collagen scaffold occurred
correlates with the progressive acellularity observed
in the implanted homograft leaflets over the 180-day
study period. In a study that evaluated cryopreserva-
tion, ice-free cryopreservation (vitrification) and
freeze-drying as preservation methods for decellular-
ized bovine pericardial scaffolds, it was found that
cryopreservation resulted in a significant increase in
stiffness and tensile strength of the scaffold, which
was not observed with the other two preservation
methods. Although cryopreservation is the preferred
method of preservation for heart valves and other
cardiovascular tissues worldwide, it does alter the
biomechanical behavior of collagenous tissues (Zou-
hair et al. 2017).
It is certainly interesting to note that the leaflet
strength did not deteriorate over this period, despite
confirmed cryopreservation damage to the collagen
scaffold as well as progressive acellularity of the
leaflets. This acellularity leaves very little hope that
damage will be repaired by cells in the leaflet.
The pristine endothelial lining of the 180 day
explants is most likely of recipient origin and may
perform an important antithrombotic function as well
as other anti-inflammatory endothelial functions,
which can attenuate thrombotic and inflammatory
processes initiated by deterioration and calcification. It
is unlikely to contribute to valvular maintenance
functions in the absence of valvular interstitial cells.
The damaged, albeit stable, state of the post
cryopreservation collagen scaffold, combined with
the lack of leaflet cellularity and absence of indica-
tions of collagen scaffold repair or new valvular
interstitial cells by 180 days, begs the question: How
do these cryopreserved homografts retain their
strength, as they clearly do in this study, as well as
in thousands of homograft recipients over many years?
Study limitations and recommendations
• Direct translation comparison to human subjects
cannot be made based on the use of the ovine
model.
• To relate the results directly to humans a primate
model must be used instead of an ovine model.
Conclusion
Although conditions of human cadaveric tissue dona-
tions were not exactly replicated in this study and
findings in animal studies can not simply be extrap-
olated to the human setting, important findings can
still be made from the results.
Post mortem harvesting time might be less impor-
tant in homograft survival than attenuating damage to
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the collagen scaffold and providing a scaffold where
recipient cells can infiltrate, proliferate and function,
thereby maintaining a normal leaflet structure. This
remains the goal of tissue-engineered heart valves and
valvular conduits.
As cryopreserved homografts still form the back-
bone of clinical homograft application, prolonging
homograft harvesting times to 48 h post mortem in this
study was not associated with early graft failure or loss
of tissue integrity. Prolonging harvesting time to 48 h
post mortem can attenuate homograft donor shortages.
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